Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Evaluation of serum levels of Sirtuin-1 in lung cancer patients Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020
Serum levels of interleukin 8 and plasma levels of osteopontin in patients with non-small cell lung cancer during chemotherapy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Alterations of serum inflammatory biomarkers in the healthy and lung cancer patients before and post chemotherapy Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021
A serum level of IGF-I and IGFBP-3 in patients with lung cancer during chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 329s Year: 2005
Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002
Prognostic value of il-6 and TNF-alfa serum concentration in advanced non-small lung cancer patients Source: Eur Respir J 2003; 22: Suppl. 45, 251s Year: 2003
Comparison of serum IL-18 levels in tuberculosis with pneumonia, lung cancer and healthy controls Source: Eur Respir J 2003; 22: Suppl. 45, 340s Year: 2003
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Serum levels of angiopoietin-1, angiopoietin-2 and their receptor- Tie-2 in patients with non small cell lung cancer during chemotherapy Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008
Plasma leptin levels in nonsmall cell lung carcinoma (NSCLC) patients at the time of the diagnosis Source: Eur Respir J 2001; 18: Suppl. 33, 65s Year: 2001
Serum levels of sFas and sFasL during chemotherapy of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 329s Year: 2005
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects. Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020
Elevated serum levels of oxidative stress biomarkers in patients with lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Plasma D-dimer level and stage of primary lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003